Is BMRN or BNTC more undervalued in 2026?

CirclFi compares BioMarin Pharmaceutical Inc. (BMRN) and Benitec Biopharma Inc. (BNTC) using 13 institutional-grade valuation models. BMRN has a Quality of Company score of 9.2/10 while BNTC scores 4.4/10.

Which is a better buy — BMRN or BNTC?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do BMRN and BNTC valuations compare?

BMRN at $57.29 and BNTC at $11.56 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

BMRN vs BNTC Valuation Comparison 2026 — Intrinsic Value Analysis

BMRN

Pharmaceutical Preparations

BioMarin Pharmaceutical Inc.

Quality

9.2

out of 10

Value Trap

—

Price

$57.29

Last close

Models

13/13

Active

BNTC

Pharmaceutical Preparations

Benitec Biopharma Inc.

Quality

4.4

out of 10

Value Trap

WARN

Price

$11.56

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	BMRN Fair Value	BMRN Upside	BNTC Fair Value	BNTC Upside
Bayesian DCF	Intrinsic	$29.06	-49.3%	$5.90	-49.0%
Earnings Power Value	Intrinsic	$21.17	-63.0%	—	—
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$19.96	-65.2%	$5.93	-48.7%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for BMRN vs BNTC — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

BMRN vs BNTC — Which Stock Is More Undervalued?

BMRN scores higher with a 9.2/10 quality rating vs BNTC's 4.4/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing BioMarin Pharmaceutical Inc. (BMRN) and Benitec Biopharma Inc. (BNTC) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

BMRN currently trades at $57.29 with a QOC of 9.2/10, while BNTC trades at $11.56 with a QOC of 4.4/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).